The promise and challenge of therapeutic genome editing

Author: Doudna, J. A.

Description: Genome editing, which involves the precise manipulation of cellular DNA sequences to alter cell fates and organism traits, has the potential to both improve our understanding of human genetics and cure genetic disease. Here I discuss the scientific, technical and ethical aspects of using CRISPR (clustered regularly interspaced short palindromic repeats) technology for therapeutic applications in humans, focusing on specific examples that highlight both opportunities and challenges. Genome editing is-or will soon be-in the clinic for several diseases, with more applications under development. The rapid pace of the field demands active efforts to ensure that this breakthrough technology is used responsibly to treat, cure and prevent genetic disease.

Subject headings: Anemia; Sickle Cell; CRISPR-Cas Systems; Gene Editing; Genome; Human; Germ-Line Mutation; Humans; Muscular Dystrophy; Duchenne; Organ Specificity; Patient Safety; beta-Globins

Publication year: 2020

Journal or book title: Nature

Volume: 578

Issue: 7794

Pages: 229–236

Find the full text:

Find more like this one (cited by):,16&hl=en

Type: Journal article

Serial number: 3129

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.